Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
92.41
+20.14 (27.87%)
At close: Oct 30, 2025, 4:00 PM EDT
90.13
-2.28 (-2.47%)
Pre-market: Oct 31, 2025, 4:44 AM EDT
Guardant Health (GH) Revenue by Segment
History
| Date | Precision Oncology Testing | Development Services |
|---|---|---|
| Dec 31, 2024 | 687.94M | 51.08M |
| Sep 30, 2024 | 645.54M | 46.72M |
| Jun 30, 2024 | 598.36M | 45.45M |
| Mar 31, 2024 | 557.09M | 46.64M |
| Dec 31, 2023 | 514.25M | 49.70M |
| Sep 30, 2023 | 485.86M | 49.93M |
| Jun 30, 2023 | 454.49M | 55.67M |
| Mar 31, 2023 | 421.31M | 60.85M |
| Dec 31, 2022 | 392.05M | 57.49M |
| Sep 30, 2022 | 366.96M | 63.80M |
| Jun 30, 2022 | 344.18M | 63.95M |
| Mar 31, 2022 | 324.72M | 66.37M |
| Dec 31, 2021 | 304.31M | 69.34M |
| Sep 30, 2021 | 280.31M | 63.55M |
| Jun 30, 2021 | 261.42M | 62.23M |
| Mar 31, 2021 | 239.81M | 58.08M |
| Dec 31, 2020 | 236.32M | 50.41M |
| Sep 30, 2020 | 229.04M | 42.28M |
| Jun 30, 2020 | 220.80M | 36.79M |
| Mar 31, 2020 | 211.87M | 33.36M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.